IANZANO, MARIANNA LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 1.809
AS - Asia 1.414
EU - Europa 1.156
AF - Africa 117
SA - Sud America 73
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.571
Nazione #
US - Stati Uniti d'America 1.769
VN - Vietnam 578
SG - Singapore 310
IT - Italia 306
CN - Cina 277
GB - Regno Unito 231
DE - Germania 136
SE - Svezia 106
HK - Hong Kong 92
FR - Francia 65
RU - Federazione Russa 64
BR - Brasile 52
IN - India 47
NL - Olanda 46
CI - Costa d'Avorio 43
IE - Irlanda 35
CA - Canada 30
TG - Togo 30
ZA - Sudafrica 29
CH - Svizzera 25
UA - Ucraina 25
JP - Giappone 24
FI - Finlandia 22
BG - Bulgaria 19
BE - Belgio 18
EE - Estonia 17
PH - Filippine 15
ID - Indonesia 10
TH - Thailandia 10
AR - Argentina 9
JO - Giordania 9
RO - Romania 9
LT - Lituania 8
PL - Polonia 8
TW - Taiwan 8
MX - Messico 7
KR - Corea 6
TR - Turchia 6
EC - Ecuador 4
BD - Bangladesh 3
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
ES - Italia 3
HR - Croazia 3
IQ - Iraq 3
PK - Pakistan 3
SC - Seychelles 3
AT - Austria 2
CO - Colombia 2
DO - Repubblica Dominicana 2
IR - Iran 2
KE - Kenya 2
NG - Nigeria 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
PY - Paraguay 1
SI - Slovenia 1
SN - Senegal 1
VE - Venezuela 1
Totale 4.571
Città #
Ashburn 213
Singapore 211
Fairfield 194
Chandler 179
Southend 178
Ho Chi Minh City 138
Hanoi 115
Ann Arbor 108
Woodbridge 94
Wilmington 91
Hong Kong 89
Houston 89
Bologna 77
Seattle 74
San Jose 58
Cambridge 57
Princeton 46
Beijing 45
Dong Ket 44
Abidjan 43
Santa Clara 39
Dublin 35
Boardman 32
Lomé 30
Bern 23
Council Bluffs 22
Haiphong 22
Bremen 21
Guangzhou 21
Lauterbourg 21
Sofia 19
Tokyo 19
Westminster 19
Brussels 18
Dallas 18
Helsinki 18
Los Angeles 18
Redwood City 18
Milan 17
Da Nang 16
Ottawa 16
Nanjing 15
Padova 14
Berlin 13
Casalecchio di Reno 13
Jinan 13
Frankfurt am Main 12
London 12
Turin 12
Amsterdam 11
Buffalo 11
Falkenstein 11
Hải Dương 11
Phoenix 11
Redmond 11
San Diego 11
New York 10
Amman 9
Hebei 9
Jakarta 9
Johannesburg 9
Nanchang 9
Redondo Beach 9
Tianjin 9
Toronto 9
Moscow 8
Atlanta 7
Can Tho 7
Changsha 7
Jacksonville 7
Jiaxing 7
Saint Petersburg 7
Shenyang 7
Bühl 6
Bắc Ninh 6
Crocetta 6
Delhi 6
Ningbo 6
Quận Ba 6
Quận Bình Thạnh 6
Warsaw 6
Des Moines 5
Montreal 5
Shanghai 5
São Paulo 5
Biên Hòa 4
Bình Phước 4
Bến Tre 4
Chieti 4
Ha Long 4
Long Xuyen 4
Nuremberg 4
Porto Recanati 4
Reggio Nell'emilia 4
Rio de Janeiro 4
Taizhou 4
Zhengzhou 4
Ankara 3
Bagni 3
Barnet 3
Totale 3.050
Nome #
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2. 380
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft 338
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 317
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. 245
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R 244
Virus-like particle display of HER2 induces potent anti-cancer responses 229
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor 227
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression 212
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy 209
In silico modeling and in vivo efficacy of cancer preventive vaccinations 197
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines 196
Evaluation of metastatic burden and recovery of human metastatic cells from a mouse model 191
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis 187
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 184
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. 184
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. 184
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy 184
Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. 177
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 175
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis 174
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 169
Functional stability, progression and evolution of targeted drug sensitivity of HER-2-positive breast cancer patient-derived xenografts 63
Totale 4.666
Categoria #
all - tutte 11.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021156 0 0 0 0 0 0 0 0 0 20 21 115
2021/2022481 28 20 41 17 50 42 14 30 32 41 106 60
2022/2023627 65 90 36 99 33 45 15 38 93 28 50 35
2023/2024158 9 26 11 17 14 19 13 22 4 12 4 7
2024/2025642 52 80 65 31 83 46 36 31 9 49 38 122
2025/20261.400 297 88 100 89 149 59 129 36 324 129 0 0
Totale 4.666